Last reviewed · How we verify
Staphylococcal infection of skin
Approved treatments
- Dalvance · AbbVie
Dalvance works by binding to the bacterial cell wall, disrupting its synthesis and ultimately leading to cell death. - Orbactiv · Melinta Therap
Orbactiv works by binding to the bacterial cell wall, disrupting its synthesis and ultimately leading to cell death. - Xydalba · Correvio International Sarl
- Orbactiv · Melinta Therapeutics, LLC
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcal infection of skin patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcal infection of skin treatment landscape brief
- Staphylococcal infection of skin treatment updates RSS
Frequently asked questions about Staphylococcal infection of skin
What drugs treat Staphylococcal infection of skin?
Tracked treatments include Dalvance, Orbactiv, Xydalba.
What is the treatment for Staphylococcal infection of skin?
Standard treatment for Staphylococcal infection of skin includes Dalvance, Orbactiv, Xydalba. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcal infection of skin patent cliff · Staphylococcal infection of skin CI report
- Treatment: Dalvance · AbbVie
- Treatment: Orbactiv · Melinta Therap
- Treatment: Xydalba · Correvio International Sarl
- Treatment: Orbactiv · Melinta Therapeutics, LLC
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing